Close Menu

NEW YORK (GenomeWeb) – The US Food and Drug Administration today granted de novo clearance that permits marketing of Hologic's Aptima assay for Mycoplasma genitalium sexually-transmitted infection in men and women.

The FDA said that this is the first test it has authorized to test for M. genitalium, a slow-growing bacterium that is difficult to detect with traditional laboratory methods and is associated with inflammation of the urethra in men and inflammation of the cervix and infection of the reproductive organs in women.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.